Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression

Journal of Immunology

Volumn 188, Issue 4, 2012, Pages 1698-1707

  Chen, Yong ^a,b   Shen, Shudan ^a   Gorentla, Balachandra K ^a   Gao, Jimin ^b   Zhong, Xiao Ping ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL DEATH; CELL EXPANSION; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION TEST; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TOR SERINE-THREONINE KINASES;

EID: 84863131186     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102448     Document Type: Article

References (49)

1. + regulatory T cells. Nat. Immunol. 4: 330-336.
2. Williams, L. M., and A. Y. Rudensky. 2007. Maintenance of the Foxp3- dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8: 277-284. (Pubitemid 46745377)
3. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787. (Pubitemid 351707693)
4. Esensten, J. H., D. Wofsy, and J. A. Bluestone. 2009. Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat. Rev. Rheumatol. 5: 560-565.
5. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
6. +) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3: 135-142.
7. +) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310.
8. +) regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
9. Hara, M., C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166: 3789-3796. (Pubitemid 32224903)
10. +naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162: 5317-5326.
11. Gavin, M. A., S. R. Clarke, E. Negrou, A. Gallegos, and A. Rudensky. 2002. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3: 33-41. (Pubitemid 34065615)
12. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
13. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
14. + regulatory T cells in vivo. J. Exp. Med. 198: 249-258.
15. Chougnet, C. A., P. Tripathi, C. S. Lages, J. Raynor, A. Sholl, P. Fink, D. R. Plas, and D. A. Hildeman. 2011. A major role for Bim in regulatory T cell homeostasis. J. Immunol. 186: 156-163.
16. Lin, W., D. Haribhai, L. M. Relland, N. Truong, M. R. Carlson, C. B. Williams, and T. A. Chatila. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8: 359-368. (Pubitemid 46745411)
17. Zhong, X. P., E. A. Hainey, B. A. Olenchock, M. S. Jordan, J. S. Maltzman, K. E. Nichols, H. Shen, and G. A. Koretzky. 2003. Enhanced T cell responses due to diacylglycerol kinase zeta deficiency. Nat. Immunol. 4: 882-890. (Pubitemid 37098659)
18. Golovina, T. N., T. Mikheeva, M. M. Suhoski, N. A. Aqui, V. C. Tai, X. Shan, R. Liu, R. R. Balcarcel, N. Fisher, B. L. Levine, et al. 2008. CD28 costimulation is essential for human T regulatory expansion and function. J. Immunol. 181: 2855-2868.
19. Bour-Jordan, H., and J. A. Bluestone. 2009. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol. Rev. 229: 41-66.
20. Hombach, A. A., D. Kofler, A. Hombach, G. Rappl, and H. Abken. 2007. Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2. J. Immunol. 179: 7924-7931.
21. Gorentla, B. K., C. K. Wan, and X. P. Zhong. 2011. Negative regulation of mTOR activation by diacylglycerol kinases. Blood 117: 4022-4031.
22. Zhong, X. P., J. Shin, B. K. Gorentla, T. O'Brien, S. Srivatsan, L. Xu, Y. Chen, D. Xie, and H. Pan. 2011. Receptor signaling in immune cell development and function. Immunol. Res. 49: 109-123.
23. Zoncu, R., A. Efeyan, and D. M. Sabatini. 2011. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12: 21-35.
24. Hickman, S. P., J. Yang, R. M. Thomas, A. D. Wells, and L. A. Turka. 2006. Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells. J. Immunol. 177: 2186-2194. (Pubitemid 44200977)
25. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151. (Pubitemid 41541792)
26. Papiernik, M., M. L. de Moraes, C. Pontoux, F. Vasseur, and C. Pénit. 1998. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10: 371-378. (Pubitemid 28182093)
27. Malek, T. R. 2008. The biology of interleukin-2. Annu. Rev. Immunol. 26: 453-479. (Pubitemid 351600382)
28. Webster, K. E., S. Walters, R. E. Kohler, T. Mrkvan, O. Boyman, C. D. Surh, S. T. Grey, and J. Sprent. 2009. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206: 751-760.
29. Vocanson, M., A. Rozieres, A. Hennino, G. Poyet, V. Gaillard, S. Renaudineau, A. Achachi, J. Benetiere, D. Kaiserlian, B. Dubois, and J. F. Nicolas. 2010. Inducible costimulator (ICOS) is a marker for highly suppressive antigenspecific T cells sharing features of TH17/TH1 and regulatory T cells. J. Allergy Clin. Immunol. 126: 280-289, 289, e1-e7.
30. + regulatory T cells in human thymus and periphery. Immunity 28: 870-880.
31. Gotsman, I., N. Grabie, R. Gupta, R. Dacosta, M. MacConmara, J. Lederer, G. Sukhova, J. L. Witztum, A. H. Sharpe, and A. H. Lichtman. 2006. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 114: 2047-2055. (Pubitemid 44706881)
32. + invariant NKT cell function and homeostatic survival. J. Immunol. 180: 5448- 5456.
33. + T regulatory cells: implications and impact on tumormediated immune suppression. J. Immunol. 180: 2967-2980.
34. Burmeister, Y., T. Lischke, A. C. Dahler, H. W. Mages, K. P. Lam, A. J. Coyle, R. A. Kroczek, and A. Hutloff. 2008. ICOS controls the pool size of effectormemory and regulatory T cells. J. Immunol. 180: 774-782.
35. Martin-Orozco, N., Y. Li, Y. Wang, S. Liu, P. Hwu, Y. J. Liu, C. Dong, and L. Radvanyi. 2010. Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells. Cancer Res. 70: 9581-9590.
36. Akbari, O., G. J. Freeman, E. H. Meyer, E. A. Greenfield, T. T. Chang, A. H. Sharpe, G. Berry, R. H. DeKruyff, and D. T. Umetsu. 2002. Antigenspecific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8: 1024-1032. (Pubitemid 35033708)
37. Gajewska, B. U., A. Tafuri, F. K. Swirski, T. Walker, J. R. Johnson, T. Shea, A. Shahinian, S. Goncharova, T. W. Mak, M. R. Stämpfli, and M. Jordana. 2005. B7RP-1 is not required for the generation of Th2 responses in a model of allergic airway inflammation but is essential for the induction of inhalation tolerance. J. Immunol. 174: 3000-3005. (Pubitemid 40279720)
38. Miyamoto, K., C. I. Kingsley, X. Zhang, C. Jabs, L. Izikson, R. A. Sobel, H. L. Weiner, V. K. Kuchroo, and A. H. Sharpe. 2005. The ICOS molecule plays a crucial role in the development of mucosal tolerance. J. Immunol. 175: 7341-7347. (Pubitemid 41713430)
39. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199: 1479-1489.
40. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116: 2423-2433.
41. + T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
42. De Rosa, V., C. Procaccini, G. Calì, G. Pirozzi, S. Fontana, S. Zappacosta, A. La Cava, and G. Matarese. 2007. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26: 241-255. (Pubitemid 46329441)
43. Zhong, X. P., R. Guo, H. Zhou, C. Liu, and C. K. Wan. 2008. Diacylglycerol kinases in immune cell function and self-tolerance. Immunol. Rev. 224: 249-264.
44. Sauer, S., L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z. A. Knight, B. S. Cobb, D. Cantrell, E. O'Connor, et al. 2008. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105: 7797-7802. (Pubitemid 351872718)
45. Liu, G., S. Burns, G. Huang, K. Boyd, R. L. Proia, R. A. Flavell, and H. Chi. 2009. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 10: 769-777.
46. Procaccini, C., V. De Rosa, M. Galgani, L. Abanni, G. Calì, A. Porcellini, F. Carbone, S. Fontana, T. L. Horvath, A. La Cava, and G. Matarese. 2010. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33: 929-941.
47. Reichardt, W., C. Dürr, D. von Elverfeldt, E. Jüttner, U. V. Gerlach, M. Yamada, B. Smith, R. S. Negrin, and R. Zeiser. 2008. Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation. J. Immunol. 181: 4770-4779.
48. Strauss, L., M. Czystowska, M. Szajnik, M. Mandapathil, and T. L. Whiteside. 2009. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. PLoS ONE 4: e5994.
49. + T cells. Blood 111: 453-462.